PDA issues essential new guidance for visual inspections
A new technical report has clarified best practice on visual inspection for visible particles in parenterals.
List view / Grid view
A new technical report has clarified best practice on visual inspection for visible particles in parenterals.
The US Food and Drug Administration (FDA) has advised manufacturers of non-sterile, water-based drug products that there have been recent product recalls due to Burkholderia cepacia complex (BCC) contamination.
Small skin patches with dissolvable microneedles were safe and well-tolerated, generated robust immunity against influenza, could be self-administered by study participants and were strongly preferred over shots.
Independent health economist lays out solution for how the UK could handle pharmaceutical regulation after Brexit.
Global logistics provider DHL Supply Chain is today opening a new pharmaceutical grade facility in Ireland.
The FDA has approved the cryopreserved formulation of ReNeuron’s human retinal progenitor cell (hRPC) therapeutic candidate...
The EMA has approved Janssen's continuous manufacturing (CM) with real-time release testing for the production of Prezista (darunavir)...
Over the last decade, research has revealed more about the human gut microbiome—the environment within the gastrointestinal tract—where microbes, especially bacteria, reside.
A new antibiotic, produced by bacteria found on a species of African ant, is very potent against antibiotic-resistant ‘superbugs’ like MRSA according to scientists.
Wickham Laboratories announces completion of validation on a fourth isolator...
A plan to tackle “serious flaws in the creation, dissemination and implementation of medical evidence” is set out by experts from The BMJ and Oxford University’s Centre for Evidence Based Medicine.
The new report highlights the significant difficulties patients and some healthcare professionals face in using evidence from research to judge the benefits and harms of medicines, and calls for concerted action to improve the information patients receive.
The Global Access to Healthcare Index measures how healthcare systems across 60 countries are working to solve the most pressing healthcare needs...
Dolomite Microfluidics is making microencapsulation technology more widely accessible with the Telos® droplet system, designed for high throughput and easy scale up...
A new deal on the breast cancer drug trastuzumab emtansine means that it can now be recommended for routine funding.